Creative Director, Oncology Brand Pitch
Developed a human-first oncology brand platform reframing Zepzelca from a clinical intervention into a quality-of-life narrative system for ES-SCLC patients, translating complex treatment science into emotionally resonant storytelling across campaign concepts, film activations, experiential installations, and visual identity frameworks.

ZEPZELCA (lurbinectedin) is a prescription medicine used to treat adults with a kind of lung cancer called small cell lung cancer (SCLC).

Outcome:
Established a differentiated narrative architecture that positioned Zepzelca as a next-generation treatment centered on patient agency, movement, and everyday life — shifting perception from disease management to life enablement.